ENTRADA THERAPEUTICS INC shareholders Q3 2023

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,659,0000.03%
PRICE T ROWE ASSOCIATES INC /MD/ 3,000,037$47,4010.01%
NATIXIS 31,186$504,5890.00%
WELLINGTON MANAGEMENT GROUP LLP 1,045,652$16,521,3010.00%
AMERICAN CENTURY COMPANIES INC 138,798$2,193,0080.00%
TD ASSET MANAGEMENT INC 119,254$1,884,2130.00%
SG Americas Securities, LLC 9,174$1450.00%
MetLife Investment Management, LLC 11,694$184,7650.00%
Ameritas Investment Partners, Inc. 1,767$27,9190.00%
FMR LLC 582,116$9,197,4330.00%

This page lists ENTRADA THERAPEUTICS INC's shareholders in Q3 2023. To view ENTRADA THERAPEUTICS INC's shareholder history, click here.